Addressing cardiovascular risks with a goal to prevent cardiovascular complications in patients undergoing antihormonal therapy for prostate cancer

Abstract Over 1 million cases of prostate cancer are reported every year, and it is the second most common cancer in men. Androgen deprivation therapy (ADT) is a hallmark treatment for prostate cancer but is associated with the development or exacerbation of cardiovascular disease. The most common c...

Full description

Bibliographic Details

Published in:	Cardio-Oncology
Main Authors:	Nishant P. Shah, Avinash Singh, Tia Higano, Derya Tilki, Neil Fleshner, Paul Nguyen, Chris Plummer, Juan Gomez Rivas, Kathleen Zhang, Ricardo Rendon, Alicia Morgans, Filipe Cirne, Darryl Leong, Daniel Lenihan, Renato D. Lopes
Format:	Article
Language:	English
Published:	BMC 2025-03-01
Subjects:	Androgen deprivation therapy Cardiovascular diseases Heart disease risk factors Prostate cancer
Online Access:	https://doi.org/10.1186/s40959-025-00318-5